Showing 5831-5840 of 20432 results for "".
- Enhancing Chemotherapy Efficacy: The Role of Vitamin D in Breast Cancer Treatmenthttps://reachmd.com/news/enhancing-chemotherapy-efficacy-the-role-of-vitamin-d-in-breast-cancer-treatment/2475154/Oncologists routinely strive to optimize breast cancer chemotherapy response, yet maximizing complete remission remains an underrecognized challenge in daily practice, particularly as clinicians seek affordable adjunctive therapies to improve
- Evolving Dynamics in Vaccine Policy: The CDC's Advisory Overhaulhttps://reachmd.com/news/evolving-dynamics-in-vaccine-policy-the-cdcs-advisory-overhaul/2475127/The recent overhaul of the CDC's Vaccine Advisory Committee under Health Secretary Robert F. Kennedy Jr. has sent ripples of surprise and concern through public health circles as appointments of individuals known for critiquing traditional va
- Evolving Roles of Caffeine in SIDS Prevention: A New Pediatric Frontierhttps://reachmd.com/news/evolving-roles-of-caffeine-in-sids-prevention-a-new-pediatric-frontier/2475145/Despite ongoing reductions in infant mortality, Sudden Infant Death Syndrome (SIDS) remains an unpredictable threat, prompting a preliminary hypothesis that caffeine may stabilize oxygen levels; however, current evidence is insufficient to in
- Understanding the Evolving Burden of Long COVID on Cardiovascular and Mental Healthhttps://reachmd.com/news/understanding-the-evolving-burden-of-long-covid-on-cardiovascular-and-mental-health/2475118/Patients recovering from severe COVID-19 are increasingly presenting with unexpected long-term cardiovascular and mental health burdens that extend far beyond acute infection, illustrating the evolving post-acute sequelae of SARS-CoV-2 infect
- Hydrafacial’s New HydraFillic with Pep9 Booster Targets Fine Line, Wrinkleshttps://reachmd.com/news/hydrafacials-new-hydrafillic-with-pep9-booster-targets-fine-line-wrinkles/2475381/The Hydrafacial Company this week announced its latest innovation, the Hydrafacial HydraFillic with Pep9TM Booster. The HydraFillic with Pep9TM Booster is Hydrafacial’s first peptide-powered booster, formulated with a new proprietary complex of 9 peptides. It’s clinically pr
- Study: Strontium Cream Could Help Manage Pruritus in HShttps://reachmd.com/news/Study-Strontium-Cream-Could-Help-Manage-Pruritus-HS/2475142/Strontium cream demonstrated promise as a therapeutic option for managing pruritus in hidradenitis suppurativa (HS), according to new research published in the Journal of Clinical and Aesthetic Dermatology. Statistical analysis of baseline and 1-week post-intervention surveys amon
- Unveiling the Paradoxical Roles of Glucocorticoid Receptors in Prostate Cancerhttps://reachmd.com/news/unveiling-the-paradoxical-roles-of-glucocorticoid-receptors-in-prostate-cancer/2475117/The glucocorticoid receptor is increasingly recognized for its paradoxical roles in both advancing and restraining prostate cancer, spotlighting new therapeutic possibilities and obstacles. Oncologists dealing with prostate cancer must
- AB Chopra Epigenetics Launches With Plan to Revolutionize Longevityhttps://reachmd.com/news/ab-chopra-epigenetics-launches-with-plan-to-revolutionize-longevity/2475380/Charles Rosier, co-founder of the Augustinus Bader skincare and biotech company, and Deepak Chopra, MD, announced the launch of AB Chopra Epigenetics, a revolutionary longevity platform that merges advanced artificial intelligence, epigenetic science, and consciousness-based healing to redefine t
- Evolving Horizons in Asthma Treatment: The Rise of Biologic Therapieshttps://reachmd.com/news/evolving-horizons-in-asthma-treatment-the-rise-of-biologic-therapies/2475114/Emerging biologic therapies offer new approaches for managing severe asthma that do not respond to conventional treatments, providing information on current developments in biologic options for pulmonologists and allergy specialists. D
- AI-Driven Models Enhance Dialysis by Forecasting and Customizing Treatmentshttps://reachmd.com/news/ai-driven-models-enhance-dialysis-by-forecasting-and-customizing-treatments/2475112/Unpredictable fluid removal rates and solute clearance, compounded by individual patient variability, continue to challenge clinicians in delivering optimal dialysis. RRI’s